"The clinical benefits of [18F]AlF-NOTA-octreotide PET/CT in ..."

Donghe Chen et al. (2025)

> Home

Details and statistics

DOI: 10.1186/S12880-025-01824-9

access: open

type: Journal Article

metadata version: 2025-07-31

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/bmcmi/ChenLWTYJZS25
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcmi/ChenLWTYJZS25
Donghe Chen, Zhenfeng Liu, Guolin Wang, Mengjiao Tu, Fei Yang, Chunting Jiang, Kui Zhao, Xinhui Su:
The clinical benefits of [¹⁸F]AlF-NOTA-octreotide PET/CT in staging and restaging patients with gastroenteropancreatic neuroendocrine neoplasms: comparison of [¹⁸F]FDG PET/CT. BMC Medical Imaging 25(1): 280 (2025)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.